BioSig Technologies, Inc. (BSGM)
USD 0.51
(-3.33%)
USD 0.51
(-3.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -28.51 Million USD | -4.57% |
| 2022 | -27.26 Million USD | 18.4% |
| 2021 | -33.41 Million USD | 43.55% |
| 2020 | -59.18 Million USD | -71.03% |
| 2019 | -34.6 Million USD | -100.46% |
| 2018 | -17.26 Million USD | -33.75% |
| 2017 | -12.9 Million USD | -15.6% |
| 2016 | -11.16 Million USD | 7.3% |
| 2015 | -12.04 Million USD | -53.07% |
| 2014 | -7.86 Million USD | -26.12% |
| 2013 | -6.23 Million USD | -175.8% |
| 2012 | -2.26 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.29 Million USD | -66.21% |
| 2024 Q1 | -3.18 Million USD | 48.37% |
| 2023 FY | -28.51 Million USD | -4.57% |
| 2023 Q2 | -10.9 Million USD | -47.68% |
| 2023 Q3 | -4.05 Million USD | 62.86% |
| 2023 Q4 | -6.16 Million USD | -52.23% |
| 2023 Q1 | -7.38 Million USD | -5.54% |
| 2022 Q2 | -5.71 Million USD | 29.13% |
| 2022 Q1 | -8.06 Million USD | 10.38% |
| 2022 Q4 | -6.99 Million USD | -7.89% |
| 2022 Q3 | -6.48 Million USD | -13.47% |
| 2022 FY | -27.26 Million USD | 18.4% |
| 2021 Q2 | -8.05 Million USD | 5.95% |
| 2021 FY | -33.41 Million USD | 43.55% |
| 2021 Q3 | -7.8 Million USD | 3.11% |
| 2021 Q4 | -8.99 Million USD | -15.36% |
| 2021 Q1 | -8.56 Million USD | 21.7% |
| 2020 Q1 | -12.8 Million USD | 15.97% |
| 2020 FY | -59.18 Million USD | -71.03% |
| 2020 Q3 | -13.1 Million USD | 41.38% |
| 2020 Q2 | -22.34 Million USD | -74.56% |
| 2020 Q4 | -10.93 Million USD | 16.55% |
| 2019 FY | -34.6 Million USD | -100.46% |
| 2019 Q1 | -5.87 Million USD | -2.99% |
| 2019 Q2 | -7.98 Million USD | -35.96% |
| 2019 Q3 | -5.5 Million USD | 31.11% |
| 2019 Q4 | -15.23 Million USD | -176.85% |
| 2018 FY | -17.26 Million USD | -33.75% |
| 2018 Q4 | -5.7 Million USD | -80.95% |
| 2018 Q3 | -3.15 Million USD | 45.33% |
| 2018 Q2 | -5.76 Million USD | -118.69% |
| 2018 Q1 | -2.63 Million USD | 48.03% |
| 2017 Q1 | -2.89 Million USD | -64.82% |
| 2017 FY | -12.9 Million USD | -15.6% |
| 2017 Q3 | -1.91 Million USD | 36.58% |
| 2017 Q4 | -5.07 Million USD | -165.09% |
| 2017 Q2 | -3.01 Million USD | -4.12% |
| 2016 Q1 | -2.31 Million USD | -10.84% |
| 2016 Q4 | -1.75 Million USD | -13.12% |
| 2016 Q3 | -1.55 Million USD | 71.91% |
| 2016 Q2 | -5.53 Million USD | -139.19% |
| 2016 FY | -11.16 Million USD | 7.3% |
| 2015 Q2 | -4.43 Million USD | -45.16% |
| 2015 FY | -12.04 Million USD | -53.07% |
| 2015 Q1 | -3.05 Million USD | -17.05% |
| 2015 Q4 | -2.08 Million USD | 15.6% |
| 2015 Q3 | -2.47 Million USD | 44.15% |
| 2014 Q4 | -2.6 Million USD | 33.9% |
| 2014 FY | -7.86 Million USD | -26.12% |
| 2014 Q1 | -728.15 Thousand USD | 17.31% |
| 2014 Q2 | -588.52 Thousand USD | 19.17% |
| 2014 Q3 | -3.94 Million USD | -570.21% |
| 2013 Q1 | -3.32 Million USD | -317.45% |
| 2013 FY | -6.23 Million USD | -175.8% |
| 2013 Q3 | -803.72 Thousand USD | 34.38% |
| 2013 Q2 | -1.22 Million USD | 63.22% |
| 2013 Q4 | -880.56 Thousand USD | -9.56% |
| 2012 FY | -2.26 Million USD | 0.0% |
| 2012 Q4 | -797.57 Thousand USD | -25.25% |
| 2012 Q3 | -636.77 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -98.538% |
| Cerus Corporation | -30.05 Million USD | 5.128% |
| OrthoPediatrics Corp. | -25.76 Million USD | -10.657% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -168.441% |
| Talis Biomedical Corporation | -66.81 Million USD | 57.327% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -64.847% |
| Inogen, Inc. | -109.38 Million USD | 73.935% |
| Spectral AI, Inc. | -12.98 Million USD | -119.593% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 54.446% |
| CVRx, Inc. | -43.1 Million USD | 33.851% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -708.163% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -129.417% |
| Orthofix Medical Inc. | -139.11 Million USD | 79.504% |
| Venus Concept Inc. | -28.3 Million USD | -0.717% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 47.227% |
| Bioventus Inc. | -81.72 Million USD | 65.112% |
| BrainsWay Ltd. | -4.92 Million USD | -478.689% |
| Envoy Medical, Inc. | -18.37 Million USD | -55.201% |
| electroCore, Inc. | -18.8 Million USD | -51.619% |
| IceCure Medical Ltd | -15.57 Million USD | -83.051% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 41.191% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -65.114% |
| MaxCyte, Inc. | -48.29 Million USD | 40.968% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -138.489% |
| Nexalin Technology, Inc. | -5.69 Million USD | -400.536% |
| PAVmed Inc | -68.79 Million USD | 58.555% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 49.592% |
| RxSight, Inc. | -50.08 Million USD | 43.073% |
| Sight Sciences, Inc. | -57.27 Million USD | 50.218% |
| SI-BONE, Inc. | -46.93 Million USD | 39.247% |
| TELA Bio, Inc. | -44.07 Million USD | 35.31% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 47.346% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 44.559% |
| LivaNova PLC | -68.49 Million USD | 58.375% |
| 908 Devices Inc. | -42.75 Million USD | 33.318% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 83.557% |
| Nemaura Medical Inc. | -9.59 Million USD | -197.148% |
| NeuroPace, Inc. | -27.17 Million USD | -4.924% |
| LENSAR, Inc. | -12.22 Million USD | -133.151% |
| Apyx Medical Corporation | -17.25 Million USD | -65.201% |
| Cutera, Inc. | -156.23 Million USD | 81.75% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -231.381% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 67.467% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -27.025% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 125.565% |
| Axonics, Inc. | -26.05 Million USD | -9.422% |
| Outset Medical, Inc. | -169.77 Million USD | 83.206% |
| IRIDEX Corporation | -10 Million USD | -184.921% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 73.883% |
| IRadimed Corporation | 20.03 Million USD | 242.308% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -245.81% |
| INVO Bioscience, Inc. | -6.76 Million USD | -321.329% |
| Telesis Bio, Inc. | -35.15 Million USD | 18.885% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 298.967% |
| Varex Imaging Corporation | 32.1 Million USD | 188.822% |
| Quipt Home Medical Corp. | 3.91 Million USD | 827.533% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -134.995% |
| Pulmonx Corporation | -61.93 Million USD | 53.965% |
| Dynatronics Corporation | -2.27 Million USD | -1154.351% |
| Modular Medical, Inc. | -17.52 Million USD | -62.656% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -94.767% |
| Semler Scientific, Inc. | 22.25 Million USD | 228.109% |
| InMode Ltd. | 195.66 Million USD | 114.572% |
| Bruker Corporation | 436.9 Million USD | 106.526% |
| Cytosorbents Corporation | -31.2 Million USD | 8.642% |
| DexCom, Inc. | 597.7 Million USD | 104.77% |
| Align Technology, Inc. | 643.33 Million USD | 104.432% |
| Viveve Medical, Inc. | -21.55 Million USD | -32.288% |
| ZimVie Inc. | -30.93 Million USD | 7.844% |
| Movano Inc. | -29.69 Million USD | 3.968% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -2.395% |
| Nexalin Technology, Inc. | -5.69 Million USD | -400.536% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -708.163% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 87.775% |
| Profound Medical Corp. | -28.61 Million USD | 0.363% |
| Insulet Corporation | 220 Million USD | 112.96% |
| enVVeno Medical Corporation | -25.23 Million USD | -12.973% |
| Surmodics, Inc. | -5.64 Million USD | -405.084% |
| iCAD, Inc. | -7.68 Million USD | -270.815% |
| Nuwellis, Inc. | -17.63 Million USD | -61.724% |
| Biotricity, Inc. | -8.82 Million USD | -222.963% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 77.22% |
| Aethlon Medical, Inc. | -12.63 Million USD | -125.631% |
| InspireMD, Inc. | -21.14 Million USD | -34.853% |
| PAVmed Inc. | -68.79 Million USD | 58.555% |
| BIOLASE, Inc. | -17.93 Million USD | -58.956% |
| Beyond Air, Inc. | -63 Million USD | 54.747% |
| FONAR Corporation | 16.53 Million USD | 272.43% |
| AxoGen, Inc. | -21.46 Million USD | -32.849% |
| Vivani Medical, Inc. | -26.96 Million USD | -5.737% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 258.04% |
| Inari Medical, Inc. | -14.03 Million USD | -103.193% |
| UFP Technologies, Inc. | 57.66 Million USD | 149.445% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -478.618% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -352.157% |
| Tenon Medical, Inc. | -15.72 Million USD | -81.293% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -281.482% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 33.237% |
| AdaptHealth Corp. | -598.4 Million USD | 95.235% |
| Sintx Technologies, Inc. | -13.35 Million USD | -113.445% |
| NanoVibronix, Inc. | -3.43 Million USD | -729.802% |
| Quanterix Corporation | -49.7 Million USD | 42.633% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -134.995% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -7363.874% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 91.475% |
| TransMedics Group, Inc. | -28.72 Million USD | 0.748% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -20.752% |
| NeuroMetrix, Inc. | -7.15 Million USD | -298.684% |
| Hyperfine, Inc. | -48.11 Million USD | 40.742% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 56.153% |
| Biomerica, Inc. | -6.36 Million USD | -347.809% |
| Bone Biologics Corporation | -9.42 Million USD | -202.409% |
| AVITA Medical, Inc. | -40.4 Million USD | 29.429% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -176.514% |
| Silk Road Medical, Inc | -59.27 Million USD | 51.896% |